| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.65B | — |
| Operating expense | — | — |
| Net income | 380.70M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EWL.F returned +11.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +5.5% |
| 1 year | +11.5% |
| 5 years | -22.7% |
| 10 years | +125.3% |
| All-time high | €115.55 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in EWL.F would be worth today ›No. Edwards Lifesciences Corporation has not paid a dividend in the past 12 months.
Edwards Lifesciences Corporation is part of the Healthcare sector.
Edwards Lifesciences Corporation has a market cap of 44.66B EUR, based on the latest quote.
Edwards Lifesciences Corporation is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
